GH Research (GHRS) Equity Average (2021 - 2025)
GH Research (GHRS) recorded quarterly Equity Average of $285.6 million in Q4 2025, down 3.95% quarter-over-quarter from $297.3 million in Q3 2025, and up 55.06% on a YoY basis from $184.2 million in Q4 2024.
GH Research (GHRS) Equity Average (2021 - 2025) Analysis & Trends
GH Research's Equity Average history runs 5 years deep, the most recent figure standing at $285.6 million for Q4 2025.
- In Q4 2025, Equity Average rose 55.06% year-over-year to $285.6 million; the TTM figure through Dec 2025 stood at $285.6 million (up 55.06% YoY), while the FY2025 annual figure was $229.3 million, up 15.26% from the prior year.
- Equity Average was $285.6 million for Q4 2025 at GH Research, down from $297.3 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $306.7 million in Q2 2025 to a low of $184.2 million in Q4 2024.
- Historically, Equity Average has averaged $247.0 million across 5 years, with a median of $245.8 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Equity Average slipped 17.18% in 2024, then surged 55.06% in 2025.
- A 5-year view of Equity Average shows it stood at $280.4 million in 2021, then decreased by 9.67% to $253.3 million in 2022, then fell by 12.2% to $222.4 million in 2023, then retreated by 17.18% to $184.2 million in 2024, then jumped by 55.06% to $285.6 million in 2025.
- The last three Equity Average figures came in at $285.6 million (Q4 2025), $297.3 million (Q3 2025), and $306.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 516.41 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 285.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 285.55 Mn |
| Sep 30, 2025 | 297.29 Mn |
| Jun 30, 2025 | 306.70 Mn |
| Mar 31, 2025 | 244.58 Mn |
| Dec 31, 2024 | 184.16 Mn |
| Sep 30, 2024 | 194.02 Mn |
| Jun 30, 2024 | 204.21 Mn |
| Mar 31, 2024 | 214.36 Mn |
| Dec 31, 2023 | 222.37 Mn |
| Sep 30, 2023 | 229.38 Mn |
| Jun 30, 2023 | 237.41 Mn |
| Mar 31, 2023 | 245.82 Mn |
| Dec 31, 2022 | 253.28 Mn |
| Sep 30, 2022 | 259.98 Mn |
| Jun 30, 2022 | 266.35 Mn |
| Mar 31, 2022 | 273.33 Mn |
| Dec 31, 2021 | 280.39 Mn |